跳至主要内容
临床试验/CTRI/2018/03/012906
CTRI/2018/03/012906招募中未知

A large multicenter,international cohort study eveluating major vascular events in patients undergoing cardiac surgery - VISION Cardiac Surgery

Population Health Research Institution0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age > 18 years
  • 2.Patients who have undergone cardiac surgery.This includes coronary artery bypass grafting and all open heart procedures such as valvular repairs/Replacement

排除标准

  • 1.Previously enrolled in the VISION Cardiac Surgery
  • 2.Patients who have undergone an isolated pericardial window,pericardiectomy,permanent pacemaker or defibrillator implantation

研究者

发起方
Population Health Research Institution

相似试验

进行中(未招募)
不适用
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2009-013884-21-DEEnceladus Pharmaceuticals BV90
进行中(未招募)
1 期
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)
EUCTR2009-013884-21-BEEnceladus Pharmaceuticals BV90
进行中(未招募)
不适用
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2009-013884-21-PLEnceladus Pharmaceuticals BV90
已完成
不适用
International prospective multicenter cohort study for validation of the Chronic Pancreatitis Prognostic Scoring System (COPPS)K86.1Other chronic pancreatitis
DRKS00022794Klinikum der Universität München, Campus Großhadern543
招募中
不适用
International multicenter observational study to determine the diagnostic sensitivity of plasma metanephrines and urinary catecholamines and metabolites compared to standard evaluation procedures in children with high risk neuroblastomaNeuroblastoma
NL-OMON51513Centre Hospitalier Universitaire Vaudois-CHUV30